Navigation Links
Video: Keppra XR(TM) Approved in the U.S.

nts living with epilepsy."

The immediate release tablet form of Keppra(R) (levetiracetam) was first approved by the FDA in 1999 as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. Since then, Keppra(R) has become the leading antiepileptic drug in the U.S.

Important Safety Information

Keppra XR(TM) extended-release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.

Keppra XR(TM) causes somnolence, dizziness, and behavioral abnormalities. The most common adverse reactions observed with Keppra XR(TM) in combination with other AEDs were somnolence and irritability.

The adverse reactions that may be seen in patients receiving Keppra XR(TM) are expected to be similar to those seen in patients receiving immediate- release Keppra(R) tablets.

Keppra(R) immediate-release tablets cause somnolence and fatigue, coordination difficulties, and behavioral abnormalities (e.g., psychotic symptoms, suicidal ideation, and other abnormalities), as well as hematological abnormalities. In adults experiencing partial onset seizures, the most common adverse reactions observed with Keppra(R) in combination with other AEDs were somnolence, asthenia, infection and dizziness.

Keppra XR(TM) should be gradually withdrawn to minimize the potential of increased seizure frequency.

Dosing must be individualized according to the patient's renal function status. The dosage should be reduced in patients with impaired renal function receiving Keppra XR. In patients with end stage renal disease on dialysis, it is recommended that immediate-release Keppra(R) be used instead of Keppra XR(TM).

For full prescribing information, please see

In order to ensure patient access to this valuable medication in the U.S., UCB is initiating a co-pay s

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. US FDA Grants Pediatric Exclusivity for UCBs Keppra(R)
10. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
(Date:10/8/2015)...  Sigma-Aldrich Corporation (NASDAQ: SIAL ) announced ... its Applied Diagnostics and Testing business segment has ... line with ten certified Snap-N-Spike ® solutions ... their stable-labeled internal standards. These new solution certified ... acid and native and deuterium-labeled analogs of cholic ...
(Date:10/8/2015)... CANADA (PRWEB) , ... October 08, 2015 , ... ... has entered into an exclusive license agreement to develop and commercialize intellectual property ... upon the original agreement from February 2009, and affords exclusive worldwide rights to ...
(Date:10/7/2015)... 8, 2015 ... accounts for largest bioinformatics market share due ... discovery and development process says this research ... . --> ... of applications, the bioinformatics market is segmented ...
(Date:10/7/2015)... (PRWEB) , ... October 07, 2015 , ... Neil Riordan, ... Beach Anti-Aging Summit Tomorrow, October 8th, at Mar-a-Lago from 3:50 pm to 4:30 pm. ... adult stem cell therapy. , He is the Co-Founder and Chief Science ...
Breaking Biology Technology:
... DNDN ) today announced that Mitchell H. Gold, ... a company update at the,UBS Global Life Sciences Conference ... 1:30 p.m. ET., A live audio webcast of ... of the Dendreon website, . If you are ...
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused ... Yin, Chairman, president & CEO, will present at ... Beijing Hotel in New York City.,The Presentation is ... PM., About Sinovac, Sinovac Biotech Ltd. ...
... SAN DIEGO, Sept. 17 Ardea Biosciences, Inc.,(Nasdaq: RDEA ) ... Biosciences, will present at two upcoming investor,conferences., UBS Global ... Time: 1:00 p.m. Eastern Time ... , Third Annual JMP Securities Healthcare Focus Conference, ...
Cached Biology Technology:
(Date:9/28/2015)... 2015 According to a new ... Product (Scanner & Others), Application (Access Control & Others), ... & Geography Global - Forecast to 2020", published by MarketsandMarkets, ... 3627.90 Million by 2020, at a CAGR of 23.40% ... market data T ables and 66 ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 This ... dominate wearable technology products today, and emerging sensor types ... have risen through the peak of the wearable technology ... the slide to disillusionment. The common feature with all ... the key enabler for their most useful functions. Sensors ...
(Date:9/9/2015)... 9, 2015  NuData Security announced today that ... furthering the company,s commitment to protecting organizations and ... NuData Security,s online fraud detection solution, NuDetect, ... cycle. The product combines continual analysis and behavioral ... behavior from fraudulent behavior, allowing the company to ...
Breaking Biology News(10 mins):
... large population of loggerhead sea turtles that nest on ... have found an unexpected dichotomy in turtle behavior: While ... bottom-dwelling sea life in shallow coastal waters, others leave ... along the African coast and exhibit a distinct feeding ...
... researchers believed that stem cells in the bone marrow ... unaware of -- and unaffected by -- the daily ... so. , Scientists at the Oklahoma Medical Research Foundation ... that eventually give rise to the blood cells that ...
... has found all forms of tobacco exposure, whether that be ... of heart attack. , The study by professors Salim Yusuf ... Medicine at McMaster University and Hamilton Health Sciences in Hamilton, ... In collaboration with colleagues from 52 countries, they calculated the ...
Cached Biology News:
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
Biology Products: